Nothing Special   »   [go: up one dir, main page]

EP3892322B1 - Appareils et procédés pour fournir des ballonnets médicaux radio-opaques - Google Patents

Appareils et procédés pour fournir des ballonnets médicaux radio-opaques Download PDF

Info

Publication number
EP3892322B1
EP3892322B1 EP21176523.5A EP21176523A EP3892322B1 EP 3892322 B1 EP3892322 B1 EP 3892322B1 EP 21176523 A EP21176523 A EP 21176523A EP 3892322 B1 EP3892322 B1 EP 3892322B1
Authority
EP
European Patent Office
Prior art keywords
balloon
parison
lattice
radiopaque
mandrel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP21176523.5A
Other languages
German (de)
English (en)
Other versions
EP3892322A1 (fr
Inventor
Hiep Do
Andrew SCHAFFER
Paul FILLMORE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ClearStream Technologies Ltd
Original Assignee
ClearStream Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ClearStream Technologies Ltd filed Critical ClearStream Technologies Ltd
Publication of EP3892322A1 publication Critical patent/EP3892322A1/fr
Application granted granted Critical
Publication of EP3892322B1 publication Critical patent/EP3892322B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M25/1027—Making of balloon catheters
    • A61M25/1029—Production methods of the balloon members, e.g. blow-moulding, extruding, deposition or by wrapping a plurality of layers of balloon material around a mandril
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
    • B29C48/25—Component parts, details or accessories; Auxiliary operations
    • B29C48/30—Extrusion nozzles or dies
    • B29C48/301—Extrusion nozzles or dies having reciprocating, oscillating or rotating parts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
    • B29C48/001—Combinations of extrusion moulding with other shaping operations
    • B29C48/0017—Combinations of extrusion moulding with other shaping operations combined with blow-moulding or thermoforming
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
    • B29C48/001—Combinations of extrusion moulding with other shaping operations
    • B29C48/0022—Combinations of extrusion moulding with other shaping operations combined with cutting
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
    • B29C48/03—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor characterised by the shape of the extruded material at extrusion
    • B29C48/09—Articles with cross-sections having partially or fully enclosed cavities, e.g. pipes or channels
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C49/00—Blow-moulding, i.e. blowing a preform or parison to a desired shape within a mould; Apparatus therefor
    • B29C49/02—Combined blow-moulding and manufacture of the preform or the parison
    • B29C49/04—Extrusion blow-moulding
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C51/00—Shaping by thermoforming, i.e. shaping sheets or sheet like preforms after heating, e.g. shaping sheets in matched moulds or by deep-drawing; Apparatus therefor
    • B29C51/008—Shaping by thermoforming, i.e. shaping sheets or sheet like preforms after heating, e.g. shaping sheets in matched moulds or by deep-drawing; Apparatus therefor without using a mould, e.g. ballooning
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M25/1027—Making of balloon catheters
    • A61M25/1029—Production methods of the balloon members, e.g. blow-moulding, extruding, deposition or by wrapping a plurality of layers of balloon material around a mandril
    • A61M2025/1031—Surface processing of balloon members, e.g. coating or deposition; Mounting additional parts onto the balloon member's surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M2025/1043—Balloon catheters with special features or adapted for special applications
    • A61M2025/1079—Balloon catheters with special features or adapted for special applications having radio-opaque markers in the region of the balloon
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2105/00—Condition, form or state of moulded material or of the material to be shaped
    • B29K2105/25—Solid
    • B29K2105/253—Preform
    • B29K2105/258—Tubular
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2031/00—Other particular articles
    • B29L2031/753—Medical equipment; Accessories therefor
    • B29L2031/7542—Catheters
    • B29L2031/7543—Balloon catheters

Definitions

  • This disclosure relates generally to balloons for performing medical procedures, such as angioplasty and, more particularly, to a balloon that is at least partially radiopaque and related methods for forming such a balloon.
  • Balloons are routinely used to resolve or address flow restrictions or perhaps even complete blockages in tubular areas of the body, such as arteries or veins. In many clinical situations, the restrictions are caused by hard solids, such as calcified plaque, and require the use of high pressures to compact such blockages.
  • Commercially available balloons employ complex technology to achieve high pressure requirements without sacrificing the profile of the balloon. Besides high pressure requirements, the balloons should also be resistant to puncture, easy to track and push, and present a low profile, especially when used for angioplasty.
  • angioplasty balloons are expanded from a deflated, folded state to an expanded state within a vessel to treat a target area, such as a portion of the circumferential inner wall I of a blood vessel V, as shown in Figures 1 and 2 .
  • the inflation is traditionally completed using an X-ray contrast agent to provide better visibility under X-ray or other form of radiography during the interventional procedure, as illustrated in Figures 3 and 3a .
  • a 70/30 percent mixture of contrast agent and saline is used to inflate the balloon during an angioplasty procedure.
  • a desirable goal is to reduce inflation and deflation times required for balloons without sacrificing the profile of the balloons, especially for large volume balloons (which can require up to two minutes of inflation/deflation times with the contrast agent).
  • the use of contrast agent prolongs the inflation/deflation times and also poses the risk of iodine exposure to patients sensitive to iodine.
  • a non-radiopaque substance could be used in lieu of the contrast agent, such as for example saline or carbon dioxide, but such substances are invisible during X-ray imaging, and thus do not enhance visibility.
  • the physician performing the angioplasty procedure should be able to locate the position of the uninflated balloon with accuracy, so that the balloon will be properly positioned once inflated. This is conventionally accomplished by attaching marker bands on the catheter shaft in the region corresponding to the balloon working surface.
  • This "working surface” is the surface along the portion of the balloon that is used to achieve the desired treatment effect, such as contacting the calcified plaque (which surface in the case of a balloon having conical or tapering sections at the proximal and distal ends is typically co-extensive with a generally cylindrical barrel section).
  • misalignment amount X between each interior marker band M carried by shaft S and working surface W of balloon 12, which also typically includes a radiopaque tip P at the distal end.
  • the resulting misalignment may prevent the clinician from accurately identifying the location of the working surface of the balloon during an interventional procedure, This may lead to a geographic misplacement, or "miss," of the intended contact between the target area T and the working surface W of the balloon 12 (see Figure 2 ). It is especially desirable to avoid such an outcome when the balloon is designed to deliver a payload (such as a drug, stent, or both) or a working element to a specified location within the vasculature, since a miss may prolong the procedure (such as, for example, by requiring redeployment of the balloon 12 or the use of another balloon catheter in the case of a drug coated balloon).
  • a payload such as a drug, stent, or both
  • the balloon may also be subject to a phenomenon known as "pancaking," In this condition, the balloon 12 folds down upon itself to a flattened state, as shown in Figure 5 . This situation may cause the balloon to be viewed through fluoroscopy as perhaps still being in the inflated condition, since the full width of the balloon may still be perceived. This can give the clinician the false perception that the balloon remains inflated, when in fact it is not.
  • the need is identified for a balloon for which the working surface may be identified during an interventional procedure with enhanced precision.
  • WO 2010/027998 Al discloses a radiopaque balloon with a composite wall having a radiopaque adhesive affixing inner and outer layers of the balloon.
  • the present invention is directed to the medical balloon of claim 1 and the method of claim 6.
  • the dependent claims refer to preferred embodiments.
  • the radiopaque material comprises a lattice
  • the method includes associating the lattice with the parison or the medical balloon.
  • the method may comprise inserting the lattice into the parison or balloon using the mandrel. This may be done after the mandrel is compressed.
  • the invention of claim 1 pertains to a medical balloon or a parison for forming a medical balloon and a mandrel including a lattice comprising a radiopaque material and configured for insertion into and expanding within the medical balloon or the parison.
  • the lattice may include a longitudinal dimension corresponding to a working surface of the balloon.
  • a catheter 10 having a distal portion 11 with a balloon 12 mounted on a catheter tube 14.
  • the balloon 12 has an intermediate section 16, or "barrel,” and end sections 18, 20.
  • the end sections 18, 20 reduce in diameter to join the intermediate section 16 to the catheter tube 14 (and thus sections 18, 20 are generally termed cones or cone sections).
  • the balloon 12 is sealed at balloon ends (proximal end 15a and distal end 15b) on the cone sections 18, 20 to allow the inflation of the balloon 12 via one or more inflation lumens 17 extending within catheter tube 14 and communicating with the interior of the balloon 12.
  • the catheter tube 14 also includes an elongated, tubular shaft 24 forming a guidewire lumen 23 that directs the guidewire 26 through the catheter 10, and along the distal end of which the balloon 12 may be located.
  • this guidewire 26 may extend through the proximal end of the catheter 10 and a first port 25 of a connector 27 into the lumen 23 to achieve an "over the wire” (OTW) arrangement, but could also be provided in a "rapid exchange"' (RX) configuration, in which the guidewire 26 exits a lateral opening 14a closer to the distal end (see Figure 9 ) or else is fed through the tip at a passage distally of the balloon 12 ("short" RX; not shown).
  • a second port 29 may also be associated with catheter 10, such as by way of connector 27, for introducing a fluid (e.g., saline, a contrast agent, or both) into the interior compartment, of the balloon 12 via the inflation lumen 17,
  • Balloon 12 may include a single or multi-layered balloon wall 28 forming the interior for receiving the inflation fluid.
  • the balloon 12 may be a non-compliant balloon having a balloon wall 28 that maintains its size and shape in one or more directions when the balloon is inflated. Examples of non-compliant balloons may be found in U.S. Pat. No. 6,746,425 and Publication Nos.
  • the balloon 12 in such case also has a pre-determined surface area that remains constant during and after inflation, also has a pre-determined length and pre-determined diameter that each, or together, remain constant during and after inflation.
  • the balloon 12 could be semi-compliant or compliant instead, depending on the particular use.
  • the balloon 12 may have a modified portion having a radiopaque quality.
  • this radiopaque quality is provided in a manner that allows for a clinician to differentiate, with relative ease and high precision, one portion of the balloon 12 from another (such as, but not limited to, the barrel section 16 including the working surface W from the cone sections 18, 20). This helps the clinician ensure the accurate positioning of the balloon 12 and, in particular, a portion of or the entire working surface W, at a specified treatment location, which may be especially desirable in the delivery of drugs via the balloon working surface W, as outlined in more detail in the following description.
  • the radiopaque quality is achieved by providing one or more at least partially radiopaque markings 30.
  • the marking or markings 30 may be provided along the balloon 12 to create a defined portion as the working surface W, as contrasted with the full length L of the balloon.
  • a marking 30 extend along the balloon 12 in a longitudinal direction along the barrel section 16 and over the entire circumference of the working surface W.
  • the marking 30 may extend over only a portion of the working surface W, or may extend over only a different part of the balloon 12 (such as the cone sections 18, 20), as outlined further in the following description.
  • This marking 30 may be provided during a process used to form the balloon 12 having the desired shape created by a multi-layered wall 28.
  • a first tube 50 comprising a thin layer of material (such as a polymer), may be inserted within a second tube 52, to form a parison 54, as shown in Figures 11 (perspective view) and 11a (cross-section).
  • the second tube 52 may also comprise a compatible polymeric material, but could also be formed of a different material (such as metal, including possibly a film).
  • the second tube 52 includes the one or more radiopaque markings 30, which may correspond in length to the barrel section 16 of the finished balloon, as shown in Figure 11 (but the second tube could extend the entire length of the balloon 12, as discussed below and illustrated by .inner tube 62 in Figure 18 ).
  • the first, inner tube 50 may then be expanded to form a multi-layered balloon 12 ( Figure 12 ), with the second, outer tube 52 thus forming a radiopaque outer sleeve, as shown in the cross-sectional view of Figure 12a .
  • this processing may be achieved using a blow mold 54 having separable portions forming a mold cavity 56 corresponding in shape to the desired shape of the balloon.
  • the outer tube 52 may be pre-positioned in the mold cavity 56, including possibly within a correspondingly shaped recess formed along one or more of the interior surfaces of the mold 55.
  • the inner tube 50 may then be expanded using heat and pressure to form the balloon 12 with the desired shape, and having the outer tube 52 intimately bonded to it.
  • Figure 14 shows that, instead of a single tube 52, two spaced rubes, such as radiopaque collars 52a, 52b, may be provided on the inner tube 50 in order to provide spaced markings 30 on the finished balloon 12 (see Figure 19 ).
  • these collars 52a, 52b may be pre-positioned in the mold cavity 56 so as to receive the inner tube 50 when inserted.
  • the collars 52, 52b may be comprised of a thin flexible, material (e.g., a polymer, such as nylon) compatible with the material (e.g., a polymer, such as nylon) of the adjacent layer formed by tube 50, but could also be made of different materials, such as one or more metal foils.
  • the collars 52a, 52b are intimately bonded to form a balloon 12 with spaced, radial markers, which as the result of the positioning at pre-determined locations in the mold cavity 56 may align precisely with the edges of the working surface W.
  • the markings 30 may be provided on the tube 52 (or tubes 52a, 52b) in various ways.
  • the markings 30 may be provided by applying a radiopaque material to the tube 52 at the desired location in any shape, pattern or form (including possibly alphanumeric characters to provide information that can be perceived under fluoroscopy, such as a length, diameter, logo, trademark, rated burst pressure, or balloon type). This may be done by inking, spraying, printing, or painting the radiopaque material in fluid form on the surface of the tube 52 (possibly with the application of a mask or the like, in which case the techniques of dipping or rolling in the radiopaque material to form the desired coating could be used).
  • the marking 30 may be embedded in the tube 52, including for example by providing it as part of a film or a felt, or in a bonding agent or adhesive used to bond multiple layers together to form the tube 52 (see, e.g., U.S. Patent Application Publication No. 2011/0160661 ).
  • the marking 30 may be provided during the process of fabricating the tube 52, such as for example during a co-extrusion process. Examples of such techniques are described in international application PCT/US 13/29974 .
  • the mold cavity may be adapted to form the balloon 12 with the desired shape and appearance, and could also be adapted to form shoulders 12a on the balloon 12 once blown. These shoulders 12a may help to retain the outer tube 52 providing the modified portion of the balloon 12 against movement in the longitudinal direction, and thus help to ensure that it remains positioned at the desired location (again, in one embodiment, aligned with the full extent of the working surface W). Additionally or alternatively, as shown in Figure 17 , the inner surface of the outer tube 52 may be adapted for fractionally engaging the outer surface of the tube 50, such as by providing a roughened or textured surface 58.
  • an adhesive may be used to improve the bond between the tubes 50, 52.
  • This adhesive may be provided on either tube prior to blow molding.
  • the adhesive may also optionally be provided with a radiopacifier in order to enhance the radiopaque quality of the balloon 12 (see, e.g., U.S. Patent Application Publication No. 2011/0160661 ).
  • a parison 60 may include an inner layer comprising a radiopaque film 62, and an outer layer 64 comprising a traditional film that is not made radiopaque by an additive.
  • the blow molding process expands the parison 60 to thus form a balloon 12 having a radiopaque quality corresponding to the length of the inner layer including radiopacifier, which may be the full length L of the balloon 12.
  • a balloon may be formed by stretching a polymer tube of constant wall thickness to a desired or preferred shape wherein the barrel portion is larger in diameter than other portions intended to be the cones or shoulders of the formed balloon.
  • Such a process may be achieved by placing a balloon parison in to a mold and altering the physical surroundings, such as increasing temperature and/or applying pressure, such as through increased fluid (gas or liquid) pressure, to allow the parison to take the shape of the surrounding mold.
  • Balloons 12 that incorporate coatings comprising drugs to be applied to the vasculature may also benefit from the above-referenced embodiments.
  • a balloon 12 including a defined working surface W such as by providing radiopaque markings 30 at the transitions between the barrel section 16 and cone sections 18, 20, may include a portion coated with such a drug D, such as one designed for achieving a desired therapeutic effect when applied to the interior of the vessel.
  • the radiopaque marking 30 may also correspond to the location of the drug D on the balloon 12, such as along the entire working surface W or only a portion of it.
  • the drag D may be applied to the inflated balloon as part of the manufacturing process, and prior to folding for insertion in the vasculature. The clinician may thus with the benefit of a fluoroscope determine the precise positioning of the working surface W prior to inflating the balloon 12 in the vasculature to deliver the drug D to the desired location and provide the desired treatment regimen.
  • the markings 30 may also be provided as one or more longitudinal strips 66 that do not extend along the entire circumference of the balloon 12, as shown in Figures 20 and 21 . This may be achieved by providing one or both of the layers 62, 64, or the tube 52, with radiopaque material corresponding to the strips 66, such as by a co-extrusion process. Additional details are provided in PCT/US13/29959 , PCT/US13/29967 , PCT/EP13/54748 , and PCT/US13/29977 . The presence of plural spaced markings 30 in this manner may also help to distinguish between the inflated condition (in which the markings are spaced), and the properly deflated condition, as the markings would be closer to each other when the balloon is folded.
  • the blow molding operation may be arranged to create a balloon 12 with a different type of modified layer.
  • an insert 52 may be provided with a functional modification, such as an outer surface that is textured or etched, and associated with an inner tube 50.
  • the insert 52 could be made partially or fully radiopaque if desired (see, e.g., Figure 10 ), but such is considered optional.
  • a multi-layered insert 52 may be provided with an outer radiopaque layer 51a and an inner support layer 51b that is not enhanced with a radiopacifier and exposed by the openings 53 formed by etchings in the outer layer (see Figure 22a ). This may create a particular pattern under fluoroscopy, which may allow for the detection of the locations on the balloon 12 where a drug is present (either on the etched portions or the unetched portions, as desired, which again may correspond to the working surface W).
  • a balloon 12 may be formed having an etched or textured outer surface layer 28a of the balloon wall 28.
  • This layer 28a may extend along the entire working surface W, as shown in Figure 23 , or any portion of it.
  • the material forming the insert 52 should have a sufficiently high melt flow index such that the features are not caused to disappear as the result of the heat and pressure created during the blow molding process.
  • the insert 52 may be provided as a reticulated or fenestrated body, such as a mesh, screen or lattice having a plurality of crossing members 57 forming openings 53.
  • the body 52 may be tubular in form, as shown, and could comprise more than one piece or part (similar to collars 52a, 52b).
  • the material forming the insert 52 should have a sufficiently high melt flow index such that the features are not caused to disappear as the result of the heat and pressure created during the blow molding process.
  • the insert 52 bonds to an inner tube 50 and forms an outer layer of the finished balloon 12.
  • the openings 53 expose the balloon wall 28, which may be adapted to form the modified layer (such as by being radiopaque).
  • the body 52 may extend along the entire working surface W, and may optionally be fully or partially radiopaque. Alternatively, the body 52 may be provided with a coating, such as in the form of a drug or an agent providing enhanced lubricity.
  • the mold 55 may be modified to provide a surface treatment on the finished balloon 12.
  • the inner surfaces of the mold cavity 56 may be provided with a textured pattern 56a, such as by etching, engraving, or the like, so as to form inwardly directed projections. This includes along the portions corresponding to the working surface W of the balloon 12 (e.g., the barrel section).
  • a parison 54 which may be a single layer of material
  • the surface of the resulting balloon 12 is provided with a corresponding pattern in the form of an impression of the pattern in the mold 55.
  • the projections forming the pattern 56a in the mold form depressions in the outer surface of the balloon wall 28.
  • An option in this example is to deposit a material within the mold cavity 56 to partially or completely fill any spaces or gaps formed in the pattern 56a, such as for example a radiopacifier 59.
  • a material within the mold cavity 56 such as for example a radiopacifier 59.
  • the balloon 12 resulting from blow molding using a mold 55 with this type of pattern 56a with a filler would thus have a surface layer modified to including the selected filler material (which in the case of a radiopacifier 59 would make the surface partially radiopaque, as shown by the darkened portions of the balloon wall 28 in Figure 28 ).
  • the depositing of the material within the mold 55 may be done by injection through an internal passageway opening within the cavity 56, either before or during the molding process, including possibly by spraying the filler material within the mold cavity 56 (such as when the mating portions forming the mold 55 are separated to expose the surface pattern 56a).
  • the balloon catheter 10 may be formed by forming a balloon parison with discrete radiopaque segments introduced by coextrusion.
  • the coextrusion may involve the use of a rotating die (see, e.g. U.S. Patent Application Publication No. 2003/0100869 ) to form discrete sections within the tube of one or more materials, such as a radiopaque material.
  • the parison may then he blow molded to form the balloon, with the radiopaque material then embedded in the walls thereof (such as between, the ends of the working surface, along the entire working surface, along one or both of the end sections or cones (see, e.g.. Figures 19-21 ), and in all cases either partly or fully providing coverage of the respective surfaces).
  • the markings 30 may further be introduced into the balloon 12 through application of a radiopaque felt.
  • a radiopaque felt 72 may also be applied to the exterior of a formed balloon 12, optionally followed by a secondary process, such as lamination (note film 74), to thereby secure the felt in position.
  • the radiopaque felt 72 may be applied over an extruded tube 76, followed by a secondary extrusion step, e.g. wire coating, to secure the felt.
  • the dual-layer tubing may then be formed into a balloon 12 by steps such as blow-molding or other similar processes known in the art
  • radiopaque material may also be applied to an inner lumen of a balloon parison 80 or fully-formed balloon 12 through the use of an expanding mandrel 82.
  • the mandrel 82 may comprise a rigid portion 82a with a distally fixed expandable portion 82b that can have both a retracted configuration, and an expanded configuration.
  • the distal section may be sized to efface the inner lumen of the balloon parison 80 when in the expanded configuration, yet still able to pass through both proximal and distal ends thereof in the retracted configuration.
  • the distal end of the mandrel 82 should be constructed of a material that can withstand gas and/or liquid pressure, such as a compliant balloon.
  • the mandrel 82 may also be comprised of opposed and/or interwoven struts arranged in a manner such that expansion may be achieved during contraction (e.g. a helically wound braid, such as a biaxial braid, wherein reduced angle between the warp and weft at crossing points in turn reduces radial distance between opposing sides) or as opposing struts connected in the middle and at each end are affected by a pivoting joint (e.g. a pantographic mechanism).
  • a helically wound braid such as a biaxial braid, wherein reduced angle between the warp and weft at crossing points in turn reduces radial distance between opposing sides
  • a pivoting joint e.g. a pantographic mechanism
  • the radiopaque material or a portion thereof may also be introduced to the balloon parison prior to molding.
  • a radiopaque material such as a film or a felt, that comprises a radiopaque material (e.g. tungsten, barium, tantalum, gold, platinum) with the addition of polymers to provide a structural matrix, as well as optionally stabilizers and/or plasticizers, can be applied to the parison prior to molding. Rolling or folding the radiopaque material allows the material to efface an inner lumen of the parison as it expands following insertion and up to or during a molding step.
  • a radiopaque material such as a film or a felt, that comprises a radiopaque material (e.g. tungsten, barium, tantalum, gold, platinum) with the addition of polymers to provide a structural matrix, as well as optionally stabilizers and/or plasticizers, can be applied to the parison prior to molding. Rolling or folding the radiopaque material allows
  • an adhesive applied to the exterior of the radiopaque material prior to insertion into the parison may further enhance in adhering the material to the balloon catheter lumen.
  • expansion of the distal tip of the mandrel discussed herein will further secure the radiopaque material.
  • the markings 30 may also be introduced to the balloon 12 as a solution.
  • a solution comprising radiopaque material 86 in suspension optionally aided by stabilizers, may be applied to the outer lumen of the expandable mandrel 82.
  • the distal portion of the expandable mandrel can then be inserted into a balloon parison (e.g., the example provided in Figure 32 ) with the mandrel in a retracted configuration (e.g., deflated, in the case of a balloon).
  • the mandrel 82 can then move to the expanded configuration to efface the parison lumen and similarly deposit the solution on the lumen surface, and the parison then used to form the balloon 12.
  • a radiopaque solution may be applied by the expandable mandrel after the balloon is fully formed.
  • the markings 30 may also comprise radiopaque fibers.
  • Fibers comprised of a radiopaque material, such as tungsten, tantalum, platinum or similar can be achieved through a polymer matrix and optionally formed through an extrusion process. Fibers can then be introduced to the balloon through the use of the expandable mandrel 80 as discussed herein.
  • the mandrel 82 can be sized in such a manner that it can be inserted in through the proximal and distal ends of the balloon parison 80 in the retracted configuration and so that it can fully efface the inner lumen of the parison in the expanded configuration.
  • fibers 88 can be arranged in a radial configuration around the mandrel 82 prior to insertion into the parison 80. Following expansion of the mandrel 82, the fibers may be deposited on the inner lumen of the parison 80, after which the mandrel can be reduced to the retracted configuration and withdrawn. Fibers may be adhered to the inner lumen through the use of an adhesive, and optionally later cured during a secondary process, such as exposure to UV light, heat, or flash-off solvents.
  • the marking 30 is introduced to the balloon 12 as a lattice or matrix 90 of radiopaque material, as shown in Figure 35 .
  • Flexible polymers embedded with radiopaque material may be formed by extrusion, optionally followed by cutting to form the lattice and thus reduce the surface area for increased flexibility.
  • the outer diameter of the lattice or matrix 90 may be sized to efface the inner lumen of a balloon parison 80 and the length of the lattice selected to correspond to the balloon barrel portion or to the cone/shoulder portions.
  • the lattice may be compressed to a smaller diameter to allow for insertion in the parison 80 through the open ends corresponding to the proximal or distal cone regions.
  • An adhesive may further be introduced to assist in anchoring to the inner lumen.
  • the marking 30 may also be applied to the balloon 12 as a powder.
  • Adhesion of a radiopaque powder may be achieved through selective application of an adhesive to the inner lumen of a parison for forming the balloon.
  • An insert such as a hypo-tube
  • An applicator e.g., a swab or sponge at the distal end, which may be expandable
  • the swab or sponge may then selectively be used to efface the cone portion of the balloon, followed by administration of an adhesive through the insert.
  • adhesive is selectively applied to the inner lumen by the sponge.
  • the balloon may then be optionally moved or rotated to enhance even distribution.
  • the insert hyper-tube
  • the insert may then be retracted and repeated through the opposing end of the balloon as needed.
  • radiopaque material which may be in the form of a powder
  • Powder not adhered to the lumen may then be removed prior to introduction of the catheter shaft.
  • a powder may be combined with the adhesive and then applied to the inner lumen through techniques such as brush coating, spray coating or flush and fill.
  • Radiopaque (RO) powder was weighed in a 20 ml glass vial which then UV light curing adhesive, 208-CTH-F Dymax (Torrington, CT) was also added. The percentages of the components were totaled to one hundred percent (100%).
  • the RO coating mixture was thoroughly mixed and transferred to a 3cc polypropylene syringe which was then placed onto a syringe pump for coating. Attached a nozzle (i.e. EFD needle tip) to the 3cc syringe and the nozzle was inserted into the lumen diameter of the balloon neck for luminal coating, only the shoulders of the balloon were coated. The infusing rate was set at 0.5 ml/minute.
  • radiopaque materials include, but are not limited to, finely divided tungsten, tantalum, bismuth, bismuth trioxide, bismuth oxychloride, bismuth subcarbonate, other bismuth compounds, barium sulfate, tin, silver, silver compounds, rare earth oxides, and many other substances commonly used for X-ray absorption.
  • the polymer used for making a film, possible with a radiopaque material may be any polymeric material which can be loaded with radiopacifier and formed into a sufficiently thin film. Examples of polymers include thermoplastic and thermoset polymers.
  • thermoplastic polymers include, but are not limited to, polyurethanes, polyamides (nylon 11, nylon 12), polyetherpolyamide copolymers such as PEBAX, polyethylene terephthalate or other polyesters, polyvinyl acetate, polyvinyl chloride, and many other thermoplastic materials useful for making films.
  • thermoset polymers include, but are not limited to, crosslinked polyurethanes, polyureas, epoxies, acrylics, silicones, and many other thermoset materials that can be formed into thin structures, including films. Any adjacent structures to be bonded, such as tubes 50, 52 or layers 62, 64, may be formed of compatible materials, which may avoid additional processing or the inclusion of a compatibilizer, tie layer or the like.

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Manufacturing & Machinery (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Blow-Moulding Or Thermoforming Of Plastics Or The Like (AREA)
  • Prostheses (AREA)

Claims (9)

  1. Ballonnet médical (12) ou paraison (80) pour former un ballonnet médical (12) et mandrin (82) incluant un treillis (90) comprenant un matériau radio-opaque et adapté pour une insertion dans et une dilatation à l'intérieur du ballonnet médical (12) ou de la paraison (80).
  2. Ballonnet médical (12) ou paraison (80) et mandrin (82) selon la revendication 1, dans lequel le treillis (90) présente une dimension longitudinale correspondant à une surface de fonctionnement (W) du ballon (12).
  3. Ballonnet médical (12) ou paraison (80) et mandrin (82) selon la revendication 1 ou 2, dans lequel le treillis (90) est formé par des polymères flexibles incorporés avec un matériau radio-opaque formé par extrusion, facultativement suivi d'une découpe.
  4. Ballonnet médical (12) ou paraison (80) et mandrin (82) selon l'une quelconque des revendications précédentes, dans lequel un diamètre externe du treillis (90) est dimensionné pour effacer une lumière intérieure de la paraison (80) et la longueur du treillis (90) est sélectionnée pour correspondre à une partie de cylindre (16) ou à une région de cône (18, 20) du ballon (12).
  5. Ballonnet médical ou paraison (80) et mandrin (82) selon la revendication 4, comprenant en outre un adhésif le long de la lumière intérieure pour connecter le treillis (90) au ballon (12).
  6. Procédé pour fournir une paraison (80) pour former un ballonnet médical (12) avec une partie radio-opaque, comprenant les étapes consistant à :
    insérer un matériau radio-opaque comprenant un treillis (90) à l'intérieur de la paraison (80) ; et mouler par soufflage la paraison (80),
    dans lequel le procédé inclut l'association du treillis à la paraison (80).
  7. Procédé selon la revendication 6, incluant en outre les étapes consistant à :
    compresser le treillis (90) ; et
    insérer le treillis dans la paraison (80) ou le ballonnet (12) en utilisant le mandrin (82).
  8. Procédé selon la revendication 6 ou 7, dans lequel le treillis (90) est compressé à un diamètre plus petit pour permettre une insertion dans la paraison (80) à travers des extrémités ouvertes correspondant aux régions de cône proximal ou distal (18, 20) du ballonnet (12).
  9. Procédé selon la revendication 6, 7 ou 8, dans lequel un adhésif est introduit pour aider le treillis (90) à s'ancrer à une lumière intérieure de la paraison (80).
EP21176523.5A 2013-08-28 2014-08-28 Appareils et procédés pour fournir des ballonnets médicaux radio-opaques Active EP3892322B1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361870913P 2013-08-28 2013-08-28
EP20160919.5A EP3682936B1 (fr) 2013-08-28 2014-08-28 Appareils et procédés pour fournir des ballonnets médicaux radio-opaques
PCT/US2014/053162 WO2015031616A2 (fr) 2013-08-28 2014-08-28 Appareils et procédés permettant de fournir des ballonnets médicaux radio-opaques
EP14777949.0A EP3038809B1 (fr) 2013-08-28 2014-08-28 Appareils et procédés permettant de fournir des ballonnets médicaux radio-opaques

Related Parent Applications (3)

Application Number Title Priority Date Filing Date
EP14777949.0A Division EP3038809B1 (fr) 2013-08-28 2014-08-28 Appareils et procédés permettant de fournir des ballonnets médicaux radio-opaques
EP20160919.5A Division EP3682936B1 (fr) 2013-08-28 2014-08-28 Appareils et procédés pour fournir des ballonnets médicaux radio-opaques
EP20160919.5A Division-Into EP3682936B1 (fr) 2013-08-28 2014-08-28 Appareils et procédés pour fournir des ballonnets médicaux radio-opaques

Publications (2)

Publication Number Publication Date
EP3892322A1 EP3892322A1 (fr) 2021-10-13
EP3892322B1 true EP3892322B1 (fr) 2022-09-28

Family

ID=51656048

Family Applications (3)

Application Number Title Priority Date Filing Date
EP20160919.5A Active EP3682936B1 (fr) 2013-08-28 2014-08-28 Appareils et procédés pour fournir des ballonnets médicaux radio-opaques
EP14777949.0A Active EP3038809B1 (fr) 2013-08-28 2014-08-28 Appareils et procédés permettant de fournir des ballonnets médicaux radio-opaques
EP21176523.5A Active EP3892322B1 (fr) 2013-08-28 2014-08-28 Appareils et procédés pour fournir des ballonnets médicaux radio-opaques

Family Applications Before (2)

Application Number Title Priority Date Filing Date
EP20160919.5A Active EP3682936B1 (fr) 2013-08-28 2014-08-28 Appareils et procédés pour fournir des ballonnets médicaux radio-opaques
EP14777949.0A Active EP3038809B1 (fr) 2013-08-28 2014-08-28 Appareils et procédés permettant de fournir des ballonnets médicaux radio-opaques

Country Status (13)

Country Link
US (2) US10869994B2 (fr)
EP (3) EP3682936B1 (fr)
JP (2) JP2016531694A (fr)
KR (2) KR102409366B1 (fr)
CN (2) CN105579215B (fr)
AU (3) AU2014312292B9 (fr)
BR (1) BR112016003597B1 (fr)
CA (1) CA2921413C (fr)
CL (1) CL2016000412A1 (fr)
MX (1) MX2016002406A (fr)
NZ (2) NZ717730A (fr)
RU (1) RU2680062C2 (fr)
WO (1) WO2015031616A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11219750B2 (en) 2008-03-21 2022-01-11 Cagent Vascular, Inc. System and method for plaque serration
BR112016003597B1 (pt) * 2013-08-28 2022-03-08 Clearstream Technologies Limited Método de formação de um balão médico e balão médico
US10463842B2 (en) 2014-06-04 2019-11-05 Cagent Vascular, Llc Cage for medical balloon
WO2016073490A1 (fr) 2014-11-03 2016-05-12 Cagent Vascular, Llc Ballonnet à dentelures
JP6817310B2 (ja) 2015-09-17 2021-01-20 ケイジェント ヴァスキュラー， エルエルシーＣａｇｅｎｔ Ｖａｓｃｕｌａｒ， Ｌｌｃ 医療用バルーンのための楔形切開器具
CN106730252A (zh) * 2015-11-18 2017-05-31 上海微创医疗器械（集团）有限公司 球囊、球囊扩张导管及球囊的制备方法
CN110290828A (zh) 2016-12-16 2019-09-27 巴德股份有限公司 医用球囊、球囊导管及其方法
EP3655085A1 (fr) * 2017-07-17 2020-05-27 Boston Scientific Scimed, Inc. Ballonnet poreux ayant un marqueur radio-opaque
US20210275781A1 (en) * 2018-07-12 2021-09-09 Hernán REBOLLEDO BERRÍOS Puncture device for accessing the vascular system
WO2020023749A1 (fr) * 2018-07-25 2020-01-30 Cagent Vascular, Llc Cathéters à ballonnet médicaux avec maniabilité améliorée

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001034062A2 (fr) * 1999-10-25 2001-05-17 Scimed Life Systems, Inc. Ballonnets stables sur le plan dimensionnel
US20010043998A1 (en) * 1999-10-25 2001-11-22 Chen John Jianhua Dimensionally stable balloons
US6325780B1 (en) * 1999-09-13 2001-12-04 Advanced Cardiovascular Systems, Inc. Inflatable member formed of liquid crystal polymeric material blend
WO2005107646A1 (fr) * 2004-05-06 2005-11-17 Cook Incorporated Système de livraison qui facilite l'inspection visuelle d'un dispositif médical intracavitaire
US20060165926A1 (en) * 2005-01-27 2006-07-27 Jan Weber Medical devices including nanocomposites

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1342243A (en) * 1970-04-28 1974-01-03 Winster Hose Ltd Flexible reinforced hose and methods of manufacturing same
US3766794A (en) * 1971-12-17 1973-10-23 Gen Electric Shaft rotation reversing device
JPS57501165A (fr) 1980-07-28 1982-07-08
US4718897A (en) 1985-09-18 1988-01-12 Chicopee Nonwoven surgical sponge with x-ray detectable element
US4771778A (en) * 1987-01-06 1988-09-20 Advanced Cardiovascular Systems, Inc. Steerable low profile balloon dilatation catheter
DE3779613D1 (de) * 1987-01-06 1992-07-09 Advanced Cardiovascular System Dilatationskatheter mit tandemballon.
JPH0251556A (ja) 1988-08-15 1990-02-21 Dainippon Ink & Chem Inc 不飽和ポリエステル樹脂組成物、成形材料及び成形物
JPH0251556U (fr) * 1988-10-04 1990-04-11
EP0388486A1 (fr) * 1989-03-20 1990-09-26 Gianfederico Dick Cathéter de dilatation PTCA orientable avec une section d'expansion réglable
AU7524391A (en) * 1990-05-15 1991-11-21 C.R. Bard Inc. Multiple layer high strength balloon for dilatation catheter
US5454788A (en) * 1991-04-24 1995-10-03 Baxter International Inc. Exchangeable integrated-wire balloon catheter
US5525388A (en) * 1992-08-07 1996-06-11 Advanced Cardiovascular Systems, Inc. Dilatation balloon with constant wall thickness
WO1994021196A2 (fr) * 1993-03-18 1994-09-29 C.R. Bard, Inc. Extenseurs endovasculaires
WO1995014501A1 (fr) * 1993-11-24 1995-06-01 Gahara William J Catheters a ballonnet opaque aux rayons x
US5587125A (en) * 1994-08-15 1996-12-24 Schneider (Usa) Inc. Non-coextrusion method of making multi-layer angioplasty balloons
JP2000070375A (ja) * 1998-09-01 2000-03-07 Togo Medikit Kk マーカーラミネートバルーンカテーテル
US20090000007A1 (en) 1998-12-07 2009-01-01 Meridian Research And Development, Inc. Nonwoven radiopaque material for medical garments and method for making same
US6756094B1 (en) 2000-02-28 2004-06-29 Scimed Life Systems, Inc. Balloon structure with PTFE component
US6932838B2 (en) * 2000-09-29 2005-08-23 Tricardia, Llc Venous valvuloplasty device and method
US20030009151A1 (en) * 2001-07-03 2003-01-09 Scimed Life Systems, Inc. Biaxially oriented multilayer polymer tube for medical devices
US6875231B2 (en) 2002-09-11 2005-04-05 3F Therapeutics, Inc. Percutaneously deliverable heart valve
US7081096B2 (en) * 2003-01-24 2006-07-25 Medtronic Vascular, Inc. Temperature mapping balloon
US8109987B2 (en) 2003-04-14 2012-02-07 Tryton Medical, Inc. Method of treating a lumenal bifurcation
US7761138B2 (en) 2004-03-12 2010-07-20 Boston Scientific Scimed, Inc. MRI and X-ray visualization
US20060004323A1 (en) 2004-04-21 2006-01-05 Exploramed Nc1, Inc. Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures
WO2006087721A2 (fr) 2005-02-17 2006-08-24 Nicast Ltd. Dispositif medical gonflable
US20070010844A1 (en) * 2005-07-08 2007-01-11 Gorman Gong Radiopaque expandable body and methods
US20090171461A1 (en) * 2005-08-26 2009-07-02 Magellan Spine Technologies, Inc. Spinal implants and methods
US20070067010A1 (en) * 2005-09-22 2007-03-22 Wang William T Center_hollowed_tubular_shaped balloon for angioplasty procedures
US7699894B2 (en) * 2005-12-22 2010-04-20 Depuy Spine, Inc. Nucleus pulposus trial device and technique
US20070219516A1 (en) 2006-03-14 2007-09-20 Tyco Healthcare Group Lp X-ray detectable element for association with surgical absorbent substrates and method of making
US20080058789A1 (en) 2006-09-06 2008-03-06 Cardiofirst Guidance system used in treating chronic occlusion
JP5023802B2 (ja) 2007-05-15 2012-09-12 株式会社カネカ 医療用バルーンとステントデリバリーシステム及びその製造方法
DE102007056946A1 (de) * 2007-11-27 2009-05-28 Gunnar Pah Vorrichtung zum Filtern von Blut
US7998576B2 (en) 2008-02-15 2011-08-16 Unitika Ltd. Radiopaque monofilament for contrast X-ray radiography
US20090299401A1 (en) * 2008-06-02 2009-12-03 Loma Vista Medical, Inc. Inflatable medical devices
WO2010028305A2 (fr) * 2008-09-05 2010-03-11 Cardiopolymers, Inc. Procédé de production de ballons d’encapsulation à microparois
CA2736084C (fr) 2008-09-05 2018-01-02 Richard Elton Ballonnet avec adhesif radio-opaque
WO2010051488A1 (fr) * 2008-10-30 2010-05-06 R4 Vascular, Inc. Ballonnet de cathéter radio-opaque souple résistant à la rupture et procédés pour l'utiliser dans une intervention chirurgicale intravasculaire
CA2645531C (fr) 2008-11-28 2016-04-12 Nova Chemicals Corporation Tissu non tisse destine a la protection contre le rayonnement
US8808357B2 (en) 2010-04-06 2014-08-19 Poly-Med, Inc. Radiopaque iodinated and iodide-containing crystalline absorbable aliphatic polymeric materials and applications thereof
EP3552655B1 (fr) * 2010-07-13 2020-12-23 Loma Vista Medical, Inc. Dispositifs médicaux gonflables
DE102010046408B4 (de) * 2010-09-23 2018-09-13 Acandis Gmbh Zuführsystem
WO2012047279A1 (fr) 2010-09-30 2012-04-12 Spinal Kinetics Inc. Prothèse de disque intervertébral ayant une gaine annulaire non homogène
US9687196B2 (en) * 2011-04-07 2017-06-27 Sanovas, Inc. Electrically conductive balloon catheter
BR112013030613B1 (pt) * 2011-06-03 2021-03-16 C.R. Bard, Inc balão médico não complacente
KR20140133843A (ko) 2012-03-09 2014-11-20 클리어스트림 테크놀러지스 리미티드 정밀하게 식별가능한 부분을 갖는 의료용 풍선
NZ702283A (en) * 2012-06-06 2016-09-30 Loma Vista Medical Inc Inflatable medical devices
BR112016003597B1 (pt) * 2013-08-28 2022-03-08 Clearstream Technologies Limited Método de formação de um balão médico e balão médico

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6325780B1 (en) * 1999-09-13 2001-12-04 Advanced Cardiovascular Systems, Inc. Inflatable member formed of liquid crystal polymeric material blend
WO2001034062A2 (fr) * 1999-10-25 2001-05-17 Scimed Life Systems, Inc. Ballonnets stables sur le plan dimensionnel
US20010043998A1 (en) * 1999-10-25 2001-11-22 Chen John Jianhua Dimensionally stable balloons
WO2005107646A1 (fr) * 2004-05-06 2005-11-17 Cook Incorporated Système de livraison qui facilite l'inspection visuelle d'un dispositif médical intracavitaire
US20060165926A1 (en) * 2005-01-27 2006-07-27 Jan Weber Medical devices including nanocomposites

Also Published As

Publication number Publication date
EP3038809B1 (fr) 2020-04-29
CN113211760A (zh) 2021-08-06
US20160206861A1 (en) 2016-07-21
KR102325260B1 (ko) 2021-11-11
CN113211760B (zh) 2023-04-25
RU2680062C2 (ru) 2019-02-14
KR20210135007A (ko) 2021-11-11
US10869994B2 (en) 2020-12-22
MX2016002406A (es) 2016-05-31
AU2014312292B2 (en) 2018-11-08
AU2019200765A1 (en) 2019-02-21
EP3682936A1 (fr) 2020-07-22
JP6748180B2 (ja) 2020-08-26
EP3892322A1 (fr) 2021-10-13
CN105579215A (zh) 2016-05-11
AU2014312292A1 (en) 2016-03-24
WO2015031616A2 (fr) 2015-03-05
AU2021202145B2 (en) 2023-04-06
BR112016003597A2 (fr) 2017-08-01
NZ717730A (en) 2020-02-28
WO2015031616A3 (fr) 2015-05-14
AU2021202145A1 (en) 2021-05-06
CA2921413C (fr) 2023-08-01
BR112016003597B1 (pt) 2022-03-08
EP3038809A2 (fr) 2016-07-06
CL2016000412A1 (es) 2017-01-27
KR20160048091A (ko) 2016-05-03
CA2921413A1 (fr) 2015-03-05
JP2016531694A (ja) 2016-10-13
NZ754529A (en) 2020-06-26
CN105579215B (zh) 2021-02-12
EP3682936B1 (fr) 2021-07-28
JP2019055259A (ja) 2019-04-11
AU2014312292B9 (en) 2020-01-30
KR102409366B1 (ko) 2022-06-15
RU2016108830A (ru) 2017-10-03
US20200345989A1 (en) 2020-11-05

Similar Documents

Publication Publication Date Title
AU2021202145B2 (en) Apparatuses and methods for providing radiopaque medical balloons
US11685097B2 (en) Parison for forming blow molded medical balloon with modified portion, medical balloon, and related methods
US20210220625A1 (en) Medical balloon with coextruded radiopaque portion
RU2719979C1 (ru) Устройство и способы получения рентгеноконтрастных медицинских баллонов

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED

AC Divisional application: reference to earlier application

Ref document number: 3038809

Country of ref document: EP

Kind code of ref document: P

Ref document number: 3682936

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20211116

RBV Designated contracting states (corrected)

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20220321

GRAJ Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTC Intention to grant announced (deleted)
INTG Intention to grant announced

Effective date: 20220711

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

GRAT Correction requested after decision to grant or after decision to maintain patent in amended form

Free format text: ORIGINAL CODE: EPIDOSNCDEC

AC Divisional application: reference to earlier application

Ref document number: 3038809

Country of ref document: EP

Kind code of ref document: P

Ref document number: 3682936

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

RAP4 Party data changed (patent owner data changed or rights of a patent transferred)

Owner name: CLEARSTREAM TECHNOLOGIES LIMITED

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602014085115

Country of ref document: DE

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1520845

Country of ref document: AT

Kind code of ref document: T

Effective date: 20221015

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220928

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220928

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20221228

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220928

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220928

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220928

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20220928

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1520845

Country of ref document: AT

Kind code of ref document: T

Effective date: 20220928

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220928

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20221229

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220928

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220928

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230130

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220928

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220928

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220928

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220928

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220928

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230128

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220928

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602014085115

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220928

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220928

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220928

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20230629

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220928

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220928

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220928

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230828

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230828

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230831

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20230831

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220928

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230831

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20240723

Year of fee payment: 11

Ref country code: IE

Payment date: 20240725

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20240723

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20240723

Year of fee payment: 11